---
title: "Nafarelin - Endometriosis"
sidebar: mydoc_sidebar
permalink: db00666-mesh-d004715-1.html
toc: false 
---


Path ID: `DB00666_MESH_D004715_1`
{% include image.html url="images/db00666-mesh-d004715-1.png" file="db00666-mesh-d004715-1.png" alt="db00666-mesh-d004715-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D017274 | nafarelin | Drug |
| UniProt:P30968 | Gonadotropin-releasing hormone receptor | Protein |
| GO:0002029 | desensitization of G protein-coupled receptor signaling pathway | BiologicalProcess |
| HP:0002027 | Abdominal pain | PhenotypicFeature |
| CHEBI:23965 | estradiol | ChemicalSubstance |
| MESH:D004715 | Endometriosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Nafarelin | INCREASES ACTIVITY OF | Gonadotropin-Releasing Hormone Receptor |
| Gonadotropin-Releasing Hormone Receptor | POSITIVELY CORRELATED WITH | Desensitization Of G Protein-Coupled Receptor Signaling Pathway |
| Desensitization Of G Protein-Coupled Receptor Signaling Pathway | NEGATIVELY CORRELATED WITH | Abdominal Pain |
| Desensitization Of G Protein-Coupled Receptor Signaling Pathway | DECREASES ABUNDANCE OF | Estradiol |
| Abdominal Pain | MANIFESTATION OF | Endometriosis |
| Estradiol | POSITIVELY CORRELATED WITH | Endometriosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00666](https://go.drugbank.com/drugs/DB00666)
